Cargando…

Advances in antitumor research of CA-4 analogs carrying quinoline scaffold

Combretastatin A-4 (CA-4) is a potent inhibitor of tubulin polymerization and a colchicine binding site inhibitor (CBSI). The structure-activity relationship study of CA-4 showed that the cis double bond configuration and the 3,4,5-trimethoxy group on the A ring were important factors to maintain th...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chao, Chang, Jing, Yang, Shanbo, Shi, Lingyu, Zhang, Yujing, Liu, Wenjing, Meng, Jingsen, Zeng, Jun, Zhang, Renshuai, Xing, Dongming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650302/
https://www.ncbi.nlm.nih.gov/pubmed/36385996
http://dx.doi.org/10.3389/fchem.2022.1040333
_version_ 1784827984438362112
author Wang, Chao
Chang, Jing
Yang, Shanbo
Shi, Lingyu
Zhang, Yujing
Liu, Wenjing
Meng, Jingsen
Zeng, Jun
Zhang, Renshuai
Xing, Dongming
author_facet Wang, Chao
Chang, Jing
Yang, Shanbo
Shi, Lingyu
Zhang, Yujing
Liu, Wenjing
Meng, Jingsen
Zeng, Jun
Zhang, Renshuai
Xing, Dongming
author_sort Wang, Chao
collection PubMed
description Combretastatin A-4 (CA-4) is a potent inhibitor of tubulin polymerization and a colchicine binding site inhibitor (CBSI). The structure-activity relationship study of CA-4 showed that the cis double bond configuration and the 3,4,5-trimethoxy group on the A ring were important factors to maintain the activity of CA-4. Therefore, starting from this condition, chemists modified the double bond and also substituted 3,4,5-trimethoxyphenyl with various heterocycles, resulting in a new generation of CA-4 analogs such as chalcone, Flavonoid derivatives, indole, imidazole, etc. Quinoline derivatives have strong biological activity and have been sought after by major researchers for their antitumor activity in recent years. This article reviews the research progress of novel CA-4 containing quinoline analogs in anti-tumor from 1992 to 2022 and expounds on the pharmacological mechanisms of these effective compounds, including but not limited to apoptosis, cell cycle, tubulin polymerization inhibition, immune Fluorescence experiments, etc., which lay the foundation for the subsequent development of CA-4 containing quinoline analogs for clinical use.
format Online
Article
Text
id pubmed-9650302
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96503022022-11-15 Advances in antitumor research of CA-4 analogs carrying quinoline scaffold Wang, Chao Chang, Jing Yang, Shanbo Shi, Lingyu Zhang, Yujing Liu, Wenjing Meng, Jingsen Zeng, Jun Zhang, Renshuai Xing, Dongming Front Chem Chemistry Combretastatin A-4 (CA-4) is a potent inhibitor of tubulin polymerization and a colchicine binding site inhibitor (CBSI). The structure-activity relationship study of CA-4 showed that the cis double bond configuration and the 3,4,5-trimethoxy group on the A ring were important factors to maintain the activity of CA-4. Therefore, starting from this condition, chemists modified the double bond and also substituted 3,4,5-trimethoxyphenyl with various heterocycles, resulting in a new generation of CA-4 analogs such as chalcone, Flavonoid derivatives, indole, imidazole, etc. Quinoline derivatives have strong biological activity and have been sought after by major researchers for their antitumor activity in recent years. This article reviews the research progress of novel CA-4 containing quinoline analogs in anti-tumor from 1992 to 2022 and expounds on the pharmacological mechanisms of these effective compounds, including but not limited to apoptosis, cell cycle, tubulin polymerization inhibition, immune Fluorescence experiments, etc., which lay the foundation for the subsequent development of CA-4 containing quinoline analogs for clinical use. Frontiers Media S.A. 2022-10-28 /pmc/articles/PMC9650302/ /pubmed/36385996 http://dx.doi.org/10.3389/fchem.2022.1040333 Text en Copyright © 2022 Wang, Chang, Yang, Shi, Zhang, Liu, Meng, Zeng, Zhang and Xing. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Chemistry
Wang, Chao
Chang, Jing
Yang, Shanbo
Shi, Lingyu
Zhang, Yujing
Liu, Wenjing
Meng, Jingsen
Zeng, Jun
Zhang, Renshuai
Xing, Dongming
Advances in antitumor research of CA-4 analogs carrying quinoline scaffold
title Advances in antitumor research of CA-4 analogs carrying quinoline scaffold
title_full Advances in antitumor research of CA-4 analogs carrying quinoline scaffold
title_fullStr Advances in antitumor research of CA-4 analogs carrying quinoline scaffold
title_full_unstemmed Advances in antitumor research of CA-4 analogs carrying quinoline scaffold
title_short Advances in antitumor research of CA-4 analogs carrying quinoline scaffold
title_sort advances in antitumor research of ca-4 analogs carrying quinoline scaffold
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650302/
https://www.ncbi.nlm.nih.gov/pubmed/36385996
http://dx.doi.org/10.3389/fchem.2022.1040333
work_keys_str_mv AT wangchao advancesinantitumorresearchofca4analogscarryingquinolinescaffold
AT changjing advancesinantitumorresearchofca4analogscarryingquinolinescaffold
AT yangshanbo advancesinantitumorresearchofca4analogscarryingquinolinescaffold
AT shilingyu advancesinantitumorresearchofca4analogscarryingquinolinescaffold
AT zhangyujing advancesinantitumorresearchofca4analogscarryingquinolinescaffold
AT liuwenjing advancesinantitumorresearchofca4analogscarryingquinolinescaffold
AT mengjingsen advancesinantitumorresearchofca4analogscarryingquinolinescaffold
AT zengjun advancesinantitumorresearchofca4analogscarryingquinolinescaffold
AT zhangrenshuai advancesinantitumorresearchofca4analogscarryingquinolinescaffold
AT xingdongming advancesinantitumorresearchofca4analogscarryingquinolinescaffold